The Pharmagellan Guide to Biotech Forecasting and Valuation PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Pharmagellan Guide to Biotech Forecasting and Valuation PDF full book. Access full book title The Pharmagellan Guide to Biotech Forecasting and Valuation by Frank S. David. Download full books in PDF and EPUB format.
Author: Frank S. David
Publisher: Pharmagellan, LLC
ISBN: 9780998407500
Category : Business & Economics
Languages : en
Pages : 138
Get Book
Book Description
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Author: Frank S. David
Publisher: Pharmagellan, LLC
ISBN: 9780998407500
Category : Business & Economics
Languages : en
Pages : 138
Get Book
Book Description
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser-or aspire to be one-then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs. The Pharmagellan Guide is a comprehensive, thoroughly referenced handbook for early-stage biopharma assets and companies.
Author: Frank David
Publisher:
ISBN: 9780998407524
Category :
Languages : en
Pages :
Get Book
Book Description
A comprehensive primer to help non-experts evaluate clinical studies of new therapies. If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. Inside this book: -- Structured roadmap for assessing the main components of a planned orcompleted biotech trial.-- Clear explanations of the most common concepts and terms in biotechclinical studies, illustrated with over 100 real-world examples.-- Deep dives on essential topics like p values, sample size calculations, andKaplan-Meier curves, written in plain English for non-statisticians.-- Pointers for interpreting positive and negative study results, understandingcommon figures and tables, and identifying red flags in press releases.If you're a biotech executive, investor, advisor, or entrepreneur--or aspire to be one--this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence."Hugely helpful. I wish I'd had a book like this earlier in my career." - SIR MENEPANGALOS, Executive VP, Biopharmaceuticals R&D, AstraZeneca"A terrific primer for non-experts looking to better evaluate new therapies." -DAPHNE ZOHAR, Founder and CEO, PureTech Health"Crisp and clear. Wise advice on when to rely on clinical data and when to beskeptical." - MICHAEL ROSENBLATT, Senior Partner, Flagship Pioneering"A source of much-needed illumination." - DAN LEPANTO, Senior ManagingDirector, M&A, SVB Leerink
Author: Regine Eibl
Publisher: John Wiley & Sons
ISBN: 1119477778
Category : Medical
Languages : en
Pages : 672
Get Book
Book Description
Authoritative guide to the principles, characteristics, engineering aspects, economics, and applications of disposables in the manufacture of biopharmaceuticals The revised and updated second edition of Single-Use Technology in Biopharmaceutical Manufacture offers a comprehensive examination of the most-commonly used disposables in the manufacture of biopharmaceuticals. The authors—noted experts on the topic—provide the essential information on the principles, characteristics, engineering aspects, economics, and applications. This authoritative guide contains the basic knowledge and information about disposable equipment. The author also discusses biopharmaceuticals’ applications through the lens of case studies that clearly illustrate the role of manufacturing, quality assurance, and environmental influences. This updated second edition revises existing information with recent developments that have taken place since the first edition was published. The book also presents the latest advances in the field of single-use technology and explores topics including applying single-use devices for microorganisms, human mesenchymal stem cells, and T-cells. This important book: • Contains an updated and end-to-end view of the development and manufacturing of single-use biologics • Helps in the identification of appropriate disposables and relevant vendors • Offers illustrative case studies that examine manufacturing, quality assurance, and environmental influences • Includes updated coverage on cross-functional/transversal dependencies, significant improvements made by suppliers, and the successful application of the single-use technologies Written for biopharmaceutical manufacturers, process developers, and biological and chemical engineers, Single-Use Technology in Biopharmaceutical Manufacture, 2nd Edition provides the information needed for professionals to come to an easier decision for or against disposable alternatives and to choose the appropriate system.
Author: Arthur G. Cook
Publisher: CRC Press
ISBN: 1317134109
Category : Business & Economics
Languages : en
Pages : 234
Get Book
Book Description
Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ’black box’ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
Author: Karl Keegan
Publisher: John Wiley & Sons
ISBN: 0470511788
Category : Business & Economics
Languages : en
Pages : 228
Get Book
Book Description
The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company
Author: Iqbal S. Grewal
Publisher: CRC Press
ISBN: 1420063219
Category : Medical
Languages : en
Pages : 372
Get Book
Book Description
Given the speed at which antibody therapy is becoming readily accepted, a comprehensive industry guide is sorely needed. Written by leading international authorities, this book maintains an overall emphasis on various therapeutic approaches and applications and provides critical discussions on the most significant areas of research in biologics. It focuses on the applications of protein biologics in autoimmunity and inflammation, hematological malignancies, and solid tumors. Each chapter clearly presents the most informative and contemporary account of its subject available, making this an unrivaled reference source beneficial to those in both academia and biotechnology industries.
Author: Martin Austin
Publisher: CRC Press
ISBN: 1317170598
Category : Business & Economics
Languages : en
Pages : 202
Get Book
Book Description
Business Development in the biotechnology and pharmaceutical industries accounts for over $5 billion in licensing deal value per year and much more than that in the value of mergers and acquisitions. Transactions range from licences to patented academic research, to product developments as licences, joint ventures and acquisition of intellectual property rights, and on to collaborations in development and marketing, locally or across the globe. Asset sales, mergers and corporate takeovers are also a part of the business development remit. The scope of the job can be immense, spanning the life-cycle of products from the earliest levels of research to the disposal of residual marketing rights, involving legal regulatory manufacturing, clinical development, sales and marketing and financial aspects. The knowledge and skills required of practitioners must be similarly broad, yet the availability of information for developing a career in business development is sparse. Martin Austin's highly practical guide spans the complete process and is based on his 30 years of experience in the industry and the well-established training programme that he has developed and delivers to pharmaceutical executives from across the world.
Author: Deborah Owen
Publisher: John Wiley & Sons
ISBN: 9781576602386
Category : Business & Economics
Languages : en
Pages : 148
Get Book
Book Description
The global financial markets turn over billions of dollars daily. An array of different instruments is available to trade in these markets, ranging from simple stocks and shares to exotic creatures such as butterfly spreads. Participation at any level involves taking a view as to which way the market in question will move. There are essentially only two methods for analysing the future direction of the markets in equities, currencies, interest rates or commodities: one involves fundamental analysis, the other technical analysis. The two camps of investment analysts are separated by a wide gulf of distrust and suspicion. This book seeks to bridge the gap between the two disciplines and show how you can benefit from both, highlighting: • The tools you can use for mapping the markets—to understand what causes shifts in the trend and underlying forces that affect the economy and therefore the financial markets • The long-term cyclical drivers—how economic change is triggered by technological change, and the technological changes that will drive the markets in the future • Downward phases of the cycle—and the factors that cause them • The markets and sectors that will prosper in the future. As the world of investment gets ever more complicated and faster, Mapping the Markets will provide an invaluable route to improving your chances of investment success and avoiding investment distress, whether you are a long-term investor or a short-term trader.
Author: Houy Phebah
Publisher: Lulu.com
ISBN: 1794808515
Category :
Languages : en
Pages : 270
Get Book
Book Description
This book shows you new tips and in-depth tutorials you need to know about the new and exciting iPhone 8 features and the iOS 13 user interface. This book would help you manage, personalize, and communicate better using your new iPhone 8, and iPhone 8 Plus cell phone optimally. You would discover how to set-up your phone correctly, how to customize the iPhone, as well as fantastic tips & tutorials you never would imagine to know about your iPhone. In this book, you will learn; -iPhone 8 correct set-up process -In-depth tutorial for optimizing iPhone -In-depth camera and photography tutorial -How to fix common iPhone 8 problems -23 Top iPhone Tips and Tricks -iPhone 8 Series Security Features -Apple ID and Face ID Set-up and Tricks -Apple Face ID Hidden Features -All iPhone 8 Gestures you should know -How to Hide SMS notification content display on iPhone screen -How to use the virtual Home button ...and a lot more. It is the complete guide for you.
Author: Dr. Rakesh Periwal
Publisher: Partridge Publishing
ISBN: 1482847906
Category : Pets
Languages : en
Pages : 110
Get Book
Book Description
When a doctor looks beyond diseases, he starts writing beyond prescriptions. The doctor here is not only the story writer, he is also one of the characters. He sees it all; hope, despair, drama, ecstasy, magic, humour, agony, denial, belief, sometimes all in a blend. The reader may have a reaction of his own! The stories are short but leave a lingering feel. There is flow, there is pause. Sometimes its like a roller coaster ride, sometimes like a dropped beat. There are intense moments; there is a lighter side to life as well. With all the technicalities of disease aside, it is the human behaviour in focus. Both of the doctor and the patient! You can read them on the move; or relaxed. You may consider them as a related experience or a totally new insight. Be whatever, you should be able to feel the intensities.
